Algae Health Sciences gets NDI for high dose astaxanthin

By Stephen Daniells contact

- Last updated on GMT

Algae Health Sciences gets NDI for high dose astaxanthin
The US Food and Drug Administration has accepted a New Dietary Ingredient (NDI) notification from Algae Health Sciences, Inc., a subsidiary of BGG, for high-dose but limited duration astaxanthin dosing.

The notification, which will be placed on public display at FDA's Division of Dockets Management as new dietary ingredient notification report number 943, lists the use of astaxanthin at a dose that does not exceed 24mg per day for a period of thirty days. 

“Based on published studies we generally recommend a dosage of 4mg – 12mg per day over longer periods; however, we are aware that a growing number of people are voluntarily dosing at well over the 12mg upper dosage range,”​ said Lixin Ding, PhD, Chief Operating Officer of AlgaeHealth. 

“In particular, many athletes report that they get better results in the 24mg per day dosage range.”​ 

The company previously had an NDI notification accepted by the FDA​ for the use of its AstaZine-branded ingredient as a bulk dietary ingredient at a dose that does not exceed 12mg of astaxanthin per day. The new 24mg per day dosage is the first in the Astaxanthin industry over 12mg per day. 

Joe Huff, CEO of AlgaeHealth’s North American operation, said the company would have preferred not to have the 30-day stipulation, but it is nevertheless happy to have something new to offer in the US market, and the company is targeting two specific niches:

1. For new users to raise their astaxanthin levels;
2. For athletes during the month leading up to an important event

On the first point, Bob Capelli, EVP Global Marketing for AlgaeHealth, told us that clinical research has shown that most people don’t feel any effects of Astaxanthin for at least two weeks, and data from studies on inflammatory conditions like joint pain have indicated that astaxanthin levels may not be fully realized after one month.

“So we see that it takes time for astaxanthin to concentrate in the body,”​ he said. “These studies were done at 12mg per day; what we hope to do is accelerate the process by a loading phase and realize the results more quickly. Our theory is that we may be able to get results at 24mg within a month that took 6 – 8 weeks to achieve at 12mg.”​  


The leading products currently on the market are formulated with a range of doses, from 4 to 12 mg per day. Kora Lazarski, Sr. Strategic Alliance Manager for SPINS LLC, told us that Nutrex Hawaii’s BioAstin is responsible for about half the dollar sales in supplements with astaxanthin as a functional ingredient, and the 12mg dosages are outselling the 4mg by almost double. 

Related news

Show more

Related products

show more

Preserve Telomere Length with ErgoActive®

Preserve Telomere Length with ErgoActive®

Blue California | 18-Jan-2021 | Product Brochure

A newly published study on ErgoActive® indicates that ergothioneine helps preserve telomere length under oxidative stress.

New Carotenoid in Town for Eye Health

New Carotenoid in Town for Eye Health

Unibar Corporation | 11-Nov-2020 | Technical / White Paper

With an increase in baby boomers, gaming, and digital use in 2020, eye health is top-of-mind among consumers.

Botanicals & Immunity: Trends & Research

Botanicals & Immunity: Trends & Research

Layn Natural Ingredients: Innovate With Our Botanical Extracts | 17-Jun-2020 | Research Study

Google Trends shows consumer searches of “Immunity” are up more than 700% in 2020 - and nutraceutical consumers are looking to botanicals. Find out everything...

Related suppliers

Follow us


View more